Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov;36(11):1904-1926.
doi: 10.1111/jdv.18429. Epub 2022 Sep 3.

European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populations

A Wollenberg  1   2 , M Kinberger  3 , B Arents  4 , N Aszodi  1 , G Avila Valle  3 , S Barbarot  5 , T Bieber  6 , H A Brough  7 , P Calzavara Pinton  8 , S Christen-Zäch  9 , M Deleuran  10 , M Dittmann  3 , C Dressler  3 , A H Fink-Wagner  11 , N Fosse  12 , K Gáspár  13 , L Gerbens  14 , U Gieler  15 , G Girolomoni  16 , S Gregoriou  17 , C G Mortz  18 , A Nast  3 , U Nygaard  19 , M Redding  20 , E M Rehbinder  21 , J Ring  22 , M Rossi  23 , E Serra-Baldrich  24 , D Simon  25 , Z Z Szalai  26 , J C Szepietowski  27 , A Torrelo  28 , T Werfel  29 , C Flohr  30   31
Affiliations
Free article

European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populations

A Wollenberg et al. J Eur Acad Dermatol Venereol. 2022 Nov.
Free article

Abstract

The evidence- and consensus-based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development Manual. Four consensus conferences were held between December 2020 and July 2021. Twenty-nine experts (including clinicians and patient representatives) from 12 European countries participated. This second part of the guideline includes recommendations and detailed information on basic therapy with emollients and moisturizers, topical anti-inflammatory treatment, antimicrobial and antipruritic treatment and UV phototherapy. Furthermore, this part of the guideline covers techniques for avoiding provocation factors, as well as dietary interventions, immunotherapy, complementary medicine and educational interventions for patients with atopic eczema and deals with occupational and psychodermatological aspects of the disease. It also contains guidance on treatment for paediatric and adolescent patients and pregnant or breastfeeding women, as well as considerations for patients who want to have a child. A chapter on the patient perspective is also provided. The first part of the guideline, published separately, contains recommendations and guidance on systemic treatment with conventional immunosuppressive drugs, biologics and janus kinase (JAK) inhibitors, as well as information on the scope and purpose of the guideline, and a section on guideline methodology.

PubMed Disclaimer

References

    1. Loden M, Andersson AC, Anderson C et al. A double-blind study comparing the effect of glycerin and urea on dry, eczematous skin in atopic patients. Acta Derm Venereol 2002; 82: 45-47.
    1. Darsow U, Lübbe J, Taïeb A et al. Position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2005; 19: 286-295.
    1. Wollenberg A, Barbarot S, Bieber T et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol 2018; 32: 657-682.
    1. van Zuuren EJ, Fedorowicz Z, Christensen R, Lavrijsen A, Arents BWM. Emollients and moisturisers for eczema. Cochrane Database Syst Rev 2017; 2: CD012119.
    1. Boralevi F, Saint Aroman M, Delarue A et al. Long-term emollient therapy improves xerosis in children with atopic dermatitis. J Eur Acad Dermatol Venereol 2014; 28: 1456-1462.